Medicure (OTCMKTS:MCUJF – Get Free Report) announced its earnings results on Friday. The company reported ($0.10) EPS for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.05), Zacks reports. Medicure had a negative net margin of 21.65% and a negative return on equity of 44.34%.
Medicure Stock Performance
Shares of OTCMKTS MCUJF traded up $0.07 during trading on Friday, hitting $0.92. The company had a trading volume of 101 shares, compared to its average volume of 3,744. Medicure has a 12 month low of $0.67 and a 12 month high of $0.97. The company has a debt-to-equity ratio of 0.03, a quick ratio of 0.73 and a current ratio of 1.04. The firm has a market capitalization of $9.55 million, a P/E ratio of -1.95 and a beta of 0.99. The stock has a 50 day simple moving average of $0.76 and a 200 day simple moving average of $0.81.
Medicure Company Profile
Medicure Pharmaceutical Corp. is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of therapies in the cardiovascular and critical?care markets. The company advances its business through a combination of in-licensing, acquisitions and strategic partnerships designed to build a diversified portfolio of prescription products that address unmet medical needs.
Headquartered in Montreal, Canada, Medicure operates in North America and selectively in Europe through licensing agreements with regional distributors.
Read More
- Five stocks we like better than Medicure
- Sony and TSMC’s $4.7 Billion Venture Is About More Than Camera Sensors
- Quantum Leaps: Debt-Free as AI Storage Demand Accelerates
- NVIDIA’s $500 Billion GPU Financing Deal Fuels Path Toward $270
- Sandisk’s Margins Look Like Software. Can They Last?
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
